USPTO 2015–2025 USPTO PatentsView US Corporation

Relamp

USPTO PatentsView assignee record - 13 granted patents across 0 technology areas, recorded in grant years 2019–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, Relamp ranks #21,680 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 0 technology areas.

#21,680
of 49,997 US assignees by volume
1st percentile
by Innovation Score (9.7/100)
1.0
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21680 · US Corporation #21,680 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-RICH

  • GRANTS-MICRO 13 grants
  • MID-PACK #21,680/49,997
  • PHOTO-FINISH RedShift BioAnalytics
  • CPC-UNK CPC blank
  • INNOV-LOW 9.7/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -100% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: RedShift BioAnalytics Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Relamp’s 9.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Relamp

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Relamp's Innovation Score is 9.7/100 (1st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Relamp?

Each dot is one of Relamp’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Relamp’s own 1.0 claims/patent is at or below the 21.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Relamp vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 12.912.91313.1 010203040 Granted patents (volume) Avg claims / patent RedShift BioAnalytics Inc. - 13, 22.62Redshift Bioanaly…Redwood Robotics Inc. - 13, 18.15Redwood RoboticsRefratechnik Holding GmbH - 13, 33.31Refratechnik Hold…RegenLab USA LLC - 13, 21.38Regenlab USARelay Therapeutics, Inc. - 13, 21.38Relay TherapeuticsRelypsa, Inc. - 13, 19.46RelypsaRenovia Inc. - 13, 7.92RenoviaRespiratory Motion, Inc. - 13, 30.69Respiratory MotionRelamp - 13, 1Relamp
Relamp vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Relamp's grants concentrate

Relamp is a focused PatentsView assignee: 0 CPC subclasses . By volume, Relamp sits between RedShift BioAnalytics Inc. and Respiratory Motion, Inc..

Who files at Relamp's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Relamp holds 13 patents at rank #21,693, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Relamp

By rank, the assignees closest to #21,693 in granted patent volume.

Relamp's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

10 1st percentile higher than 1% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Relamp patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 13 100.0%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Relamp's patent record in context - here's where to go next.

  • Ranked #21,680 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Relamp against RedShift BioAnalytics Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 9.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.